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This Article contains an error in Panel D of Figure 3. The third pathological image (S1PR1 ECKO + Vehicle) is a duplicate of the fourth pathological image (S1PR1 ECKO + CYM-5442), and therefore incorrect. The correct version of Figure [3](#Fig3){ref-type="fig"} is reproduced below.Figure 3Administration of CYM-5442 ameliorates ALI induced by H1N1 virus infection in control mice, but no effect was observed on*S1PR1 ECKO* mice. Control and *S1PR1 ECKO* mice were infected with 10^5.5^ TCID50 of influenza A virus and treated with either vehicle or CYM-5442.**(A)** Body weight change curves (n = 20). The differences between vehicle and CYM-5442-treated control mice were significant (P \< 0.001).**(B)** Kaplan-Meier survival curves (n = 20). Control mice treated with CYM-5442 survived longer than untreated control mice (P = 0.033).**(C)** Wet/dry ratios of lungs from infected mice (n = 6).**(D)** Representative pathological images of the lungs on day 5 post-infection. Lung injury was significantly less in control mice receiving CYM-5442 with less pulmonary consolidation, exudation in alveolar air space, vascular haemorrhage and inflammatory infiltrates than lung injury in vehicle recipients. Magnification: 200× ; scale bars, 100 μm.**(E)** Relative average quantification of inflammatory cells in lung tissues on day 5 post-infection (n = 5).**(F)** Concentrations of cytokines/chemokines were measured at 48 hours post-infection by ELISA in BALF (n = 5).**(G)** Viral loads of 2009 H1N1 in lung tissues on day 3 post-infection (n = 5). Using uninfected mice lung RNA as a baseline, equivalent levels of influenza virus RNA occurred in all four groups. \*P \< 0.05, \*\*P \< 0.01 and \*\*\*P \< 0.001. These data are representative of three experiments and are shown as the means ± SEM.
